Agilent Technologies (NYSE:A) Price Target Raised to $168.00

Agilent Technologies (NYSE:AGet Rating) had its target price lifted by Cowen from $160.00 to $168.00 in a research report sent to investors on Tuesday morning, The Fly reports.

Several other research analysts also recently weighed in on A. Bank of America increased their price target on Agilent Technologies from $148.00 to $155.00 and gave the stock a buy rating in a research note on Wednesday, August 17th. KeyCorp increased their price target on Agilent Technologies from $155.00 to $165.00 and gave the stock an overweight rating in a research note on Tuesday. SVB Leerink increased their price target on Agilent Technologies from $145.00 to $160.00 and gave the stock an outperform rating in a research note on Tuesday. Robert W. Baird increased their price target on Agilent Technologies from $160.00 to $170.00 in a research note on Tuesday. Finally, Cowen increased their price target on Agilent Technologies to $160.00 in a research note on Monday, August 22nd. Four research analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of Moderate Buy and a consensus target price of $157.00.

Agilent Technologies Trading Down 1.0 %

Shares of Agilent Technologies stock opened at $155.35 on Tuesday. Agilent Technologies has a 1 year low of $112.52 and a 1 year high of $162.62. The firm has a market cap of $45.99 billion, a PE ratio of 37.25, a P/E/G ratio of 2.78 and a beta of 1.06. The stock has a fifty day moving average price of $133.99 and a 200-day moving average price of $128.48. The company has a debt-to-equity ratio of 0.52, a current ratio of 2.03 and a quick ratio of 1.41.

Agilent Technologies (NYSE:AGet Rating) last announced its earnings results on Monday, November 21st. The medical research company reported $1.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.14. The firm had revenue of $1.85 billion during the quarter, compared to analyst estimates of $1.76 billion. Agilent Technologies had a return on equity of 30.31% and a net margin of 18.31%. The business’s revenue was up 11.4% compared to the same quarter last year. During the same period last year, the firm posted $1.21 EPS. Equities research analysts anticipate that Agilent Technologies will post 5.64 EPS for the current year.

Agilent Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 25th. Stockholders of record on Tuesday, January 3rd will be paid a $0.225 dividend. The ex-dividend date of this dividend is Friday, December 30th. This represents a $0.90 annualized dividend and a dividend yield of 0.58%. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.21. Agilent Technologies’s payout ratio is currently 20.14%.

Insider Transactions at Agilent Technologies

In other news, SVP Michael Tang sold 7,545 shares of the business’s stock in a transaction on Tuesday, November 22nd. The stock was sold at an average price of $153.90, for a total value of $1,161,175.50. Following the completion of the transaction, the senior vice president now owns 46,499 shares in the company, valued at $7,156,196.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, SVP Michael Tang sold 7,545 shares of the company’s stock in a transaction on Tuesday, November 22nd. The stock was sold at an average price of $153.90, for a total transaction of $1,161,175.50. Following the completion of the sale, the senior vice president now owns 46,499 shares in the company, valued at $7,156,196.10. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, VP Padraig Mcdonnell sold 2,103 shares of the company’s stock in a transaction on Wednesday, September 28th. The shares were sold at an average price of $122.89, for a total value of $258,437.67. Following the sale, the vice president now owns 13,217 shares of the company’s stock, valued at approximately $1,624,237.13. The disclosure for this sale can be found here. Insiders sold 174,326 shares of company stock worth $26,474,537 over the last quarter.

Institutional Trading of Agilent Technologies

A number of hedge funds have recently bought and sold shares of A. Toroso Investments LLC grew its holdings in Agilent Technologies by 9.6% during the third quarter. Toroso Investments LLC now owns 6,568 shares of the medical research company’s stock valued at $797,000 after purchasing an additional 577 shares during the period. CVA Family Office LLC grew its holdings in Agilent Technologies by 722.2% during the third quarter. CVA Family Office LLC now owns 370 shares of the medical research company’s stock valued at $45,000 after purchasing an additional 325 shares during the period. IHT Wealth Management LLC bought a new stake in Agilent Technologies during the third quarter valued at about $359,000. B. Riley Wealth Advisors Inc. grew its holdings in Agilent Technologies by 5.8% during the third quarter. B. Riley Wealth Advisors Inc. now owns 5,086 shares of the medical research company’s stock valued at $619,000 after purchasing an additional 278 shares during the period. Finally, Teachers Retirement System of The State of Kentucky bought a new stake in Agilent Technologies during the third quarter valued at about $3,401,000.

Agilent Technologies Company Profile

(Get Rating)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

Read More

The Fly logo

Analyst Recommendations for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.